Go Pro
NYSEARCA:FBT

First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News

First Trust NYSE Arca Biotechnology Index Fund logo
$270.93 0.00 (0.00%)
As of 09/4/2026 04:10 PM Eastern

About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)

Advanced

Key Stats

Today's Range
$270.40
$271.48
50-Day Range
$245.06
$273.91
52-Week Range
$173.98
$274.99
Volume
21,158 shs
Average Volume
115,062 shs
Market Capitalization
$2.99 billion
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.60%
Aggregate Rating
Moderate Buy

ETF Overview

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

First Trust NYSE Arca Biotechnology Index Fund Expenses

TypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.60%0.55%0.57%0.50%0.53%
Other Expenses0.00%0.52%0.53%0.60%0.54%
Total Expense0.60%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.78%-0.68%
Net Expense0.60%0.58%0.63%0.57%0.60%
Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FBT ETF News Headlines

(FBT) First Trust NYSE Arca Biotechnology Index Fund
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Headlines

FBT ETF - Frequently Asked Questions

First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $206.52 on January 1st, 2026. Since then, FBT shares have increased by 31.2% and is now trading at $270.93.

Top institutional investors of First Trust NYSE Arca Biotechnology Index Fund include Nilsine Partners LLC (0.88%), TD Waterhouse Canada Inc. (0.43%), Ocean Park Asset Management LLC (0.08%) and Quad Cities Investment Group LLC (0.08%).

Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology Index Fund investors own include DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
First Trust
Fund Name
First Trust NYSE Arca Biotechnology Index Fund
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:FBT
Inception Date
6/19/2006
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Arca Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
31

Fund Statistics

Assets Under Management
$0.00
Average Daily Volume
$43.28 thousand
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Options

Optionable
Optionable
Options Volume
3
Put Options
0
Call Options
3
Short Interest
22,683 shs

Miscellaneous

Beta
0.67
Creation Unit
50,000
Creation Fee
$500.00
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 FBT Holdings

FBT Sector Exposure

FBT Industry Exposure


This page (NYSEARCA:FBT) was last updated on 9/7/2026 by MarketBeat.com Staff.
From Our Partners